Abstracts

ABSTRACTS
The Scientific Committee welcomes the submission of abstracts of original contributions to the Congress.
Abstracts will be reviewed by the Scientific Committee and may be selected for either oral or poster presentation.
Abstracts should be submitted in English.
Notification of acceptance by the Scientific Committee will be mailed to the presenting Author.

GENERAL GUIDELINES
Your abstract submission must meet the following criteria for  consideration:
•    The Congress will accept an abstract submission if the abstract:
- has not been submitted for publication, or
- has been submitted for publication but not yet accepted for publication by June 1st, 2018
•    The Congress will not accept an abstract submission if the abstract has already been published.
•    The lead author (i.e., individual submitting the abstract and presenting the abstract if accepted) has the authority to submit the abstract and transfer copyright on behalf of the co-authors and company sponsors.
•    All research and studies in submitted abstracts must comply with the WMA Declaration of Helsinki, the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, and the NIH Guide for the Care and Use of Laboratory Animals.

SUBMISSION INFORMATION
1.    All abstracts must be submitted electronically through the Congress submission site by Wednesday, January 10th, 2018 for consideration.
2.    A lead author must be assigned for each abstract submission.
3.    This individual is the first author listed in the submission and has the primary responsibility for communications with the congress.
4.    This individual is responsible for ensuring that all co-authors and company sponsors approve the submission, publication, and potential presentation.
5.    This individual will give the oral or poster presentation if the submission is accepted. The lead author should feel comfortable presenting and answering questions in English.

AUTHORS and CONTRIBUTORS
With regard to authorship credit, the Congress has adopted the criteria recommended by the International Committee of Medical Journal Editors (ICMJE) in the current update of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

"Authorship credit should be based on
1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2) drafting the article or revising it critically for important intellectual content; and
3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3."

INSTRUCTIONS FOR ELECTRONIC SUBMISSION
PLEASE NOTE: No faxed or e-mailed abstract will be accepted.
- The title of the abstract should be printed in initial capital letters followed by lower case.
- The name(s) of the Author(s) should be preceded by the initials (please omit titles).
- Organization should be abbreviated, with capitalization as in title.
- Each contributor has to put each surname first, without abbreviating this to an initial. Also, do not put full capitals to highlight what is the surname, but just use an initial capital.
- The submitting author is responsible also for the correct use of initials and surnames of their co-authors.
- Affiliations: all authors should have an affiliation, at least with a basic entry including the country.
- The structure of the abstracts should include an introduction, methods, results and key conclusions.
- Abbreviations should be defined by being placed in parentheses immediately after the full word or phrase has been typed for the first time.
- No graphs, figures, tables or unusual symbols can be included.
- Place citations to references in square brackets, eg [1].
- If there are references after the abstract, there should also be citations to the refs in the abstract, and vice versa.
- Decimal punctuation is with a decimal point (in English), not with comma.
- Generic (nonproprietary) names should be used for drugs and substances.
- An abstract submission may contain a maximum of 2,500 characters, and the count includes characters and spaces.

Primary responsibility for compliance with any disclosure or nondisclosure requirements resides solely with researchers.

CHANGES
It is important that the lead author checks the abstract data carefully before submission.
No changes will be allowed, including author updates.
If accepted for presentation/publication, your abstract will be printed as it was submitted with any changes.

WITHDRAWALS
The lead author can request abstract withdrawal by May 15, 2018 by emailing
icrnm18@aristea.com

ASSIGNMEMT, NOTIFICATION & PRESENTATION
All abstract submissions are peer reviewed and authors' names and institutions are blinded to reviewers.
The Congress will email notifications to the lead authors of all abstract submissions by April 30, 2018.

Detailed information, guidelines and recommendations for oral or poster presentation, as well as time allotment, date, hour and venue will be sent by e-mail to the registered presenting Author.

At least one Author of accepted abstracts are required to register and pay the registration fee to ensure the rights for the presentation.

The Congress is unable to support any participation cost related to submitted abstract, including but not limited to registration, travel and accommodation.

TOPIC:
- Nutrition in CKD
- Enteral and parenteral feeding
- Low protein and keto acid supplemented diets: clinical applications
- Obesity, diabetes and the kidney
- Uremic toxins
- Lipids in renal disease
- Inflammation and oxidative stress
- Mineral bone disease
- Miscellaneous